Next Article in Journal
Bridging from Brain to Tumor Imaging: (S)-(−)- and (R)-(+)-[18F]Fluspidine for Investigation of Sigma-1 Receptors in Tumor-Bearing Mice
Next Article in Special Issue
Synthesis and Fluorescence Properties of a New Heterotrinuclear Co(II)-Ce(III)Complex Constructed from a bis(salamo)-Type Tetraoxime Ligand
Previous Article in Journal
Friedelin in Maytenus ilicifolia Is Produced by Friedelin Synthase Isoforms
Previous Article in Special Issue
Ni(II) Complexes with Schiff Base Ligands: Preparation, Characterization, DNA/Protein Interaction and Cytotoxicity Studies
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 23
Issue 3
10.3390/molecules23030701
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis, Characterization, Crystal Structure, and DFT Study of a New Square Planar Cu(II) Complex Containing Bulky Adamantane Ligand

by
Monther A. Khanfar
*,
Areej M. Jaber
,
Murad A. AlDamen
and
Raed A. Al-Qawasmeh
Department of Chemistry, Faculty of Science, the University of Jordan, Amman 11942, Jordan
*
Author to whom correspondence should be addressed.
Molecules 2018, 23(3), 701; https://doi.org/10.3390/molecules23030701
Submission received: 26 February 2018 / Revised: 9 March 2018 / Accepted: 13 March 2018 / Published: 20 March 2018
(This article belongs to the Special Issue Metal Complexes of Biological Ligands)
Browse Figures
Versions Notes

Abstract

:
A copper complex with square planar geometry, [(L)CuBr2] (1), (L = N′-(furan-2-ylmethylene)adamantne-1-carbohydrazide) has been synthesized and characterized by Fourier transfer infrared (FTIR) spectroscopy, elemental analysis, mass spectrometry, and single crystal X-ray diffraction. The crystal of 1 is solved as monoclinic, space group P21/m with unit cell parameters: a = 10.8030(8), b = 6.6115(8), c = 12.1264(12) Å, β = 101.124(8)°, V = 849.84(15) Å3, Z = 2, and R1 = 0.0751 with wR2 = 0.1581 (I > 2 σ). The structure of 1 shows intramolecular hydrogen bonding between the N–H and the furan oxygen which stabilizes the configuration of the complex. Furthermore, inside the lattice there are other weak interactions between bromo ligands and the ligand L. DFT calculations where performed to study the stability of this geometry.

Graphical Abstract

1. Introduction

Hydrazones constitute an important class of compounds and have been extensively studied due to their rapid access, availability, and diversity. Incorporation of a carbonyl group to hydrazones forms the acrylhydrazones, which in turn have an additional ligating site. Compounds of this type were accessed due to their biological significance as, for example, antifungal [1,2] antimicrobial [3,4,5,6,7,8,9], and anticancer [10,11,12] agents. Furthermore, an adamantane moiety has been known to enhance biological significance when anchored on certain scaffolds [13,14,15,16,17,18]. On the other hand, numerous instances of metabolism and transportation of metal ions and complexes have been established, as well as the importance of introducing adamantane on metal ion-containing hydrazones, yet less attention was devoted to such compounds [19,20,21,22]. Copper is considered to be an essential trace element in biological systems [23,24,25]. The importance of the coordination of copper with ligands containing adamantane [26] has also been investigated. Recently, copper complexes as a substitute of cisplatin complexes as anticancer agents have been reviewed [27,28]. Among the variety of coordination numbers and geometry that copper could deliver, the square planar geometry would be most attractive. Nevertheless, incorporation of metal ions with biologically active ligands may not enhance the activity. This may be attributed to structural changes that the metal ion could make in the structure of the organic ligand [29]. It is still a challenging task to collect active functional groups in a compound, especially for drugs [29]. Quite recently, we reported the synthesis of new adamantane-containing hydrazone compounds, where furan was one of the arms within the hydrazine-adamantyl compounds [30,31]. Herein, we report on the synthesis and study of the structural properties of copper(II) complex of N′-(furan-2-ylmethylene)adamantne-1-carbohydrazide which may possess a potent anticancer activity. Interestingly, the synthesized complex showed a symmetrical square planar geometry as indicated by X-ray single crystal crystallography.

2. Results and Discussion

2.1. Preparation and Characterization of the Copper(II) Complex

The ligand was prepared as described [30,31] by refluxing an equimolar mixture of admantane-1-carboxylic acid hydrazine with furane-2-caebaldehyde in ethanol to produce the desired ligand, which was identified with an authentic sample [30,31]. The reaction of L with copper(II) bromide (CuBr2) under the solvothermal condition results in the formation of Cu(II) complex (Scheme 1). High resolution mass spectrometry (HRMS) of the complex gave the corresponding exact molecular mass. IR bands υ (cm−1) assigned to stretching (C=O) at 1593 (s) cm−1 and (C=N) at 1526 (s) cm−1 clearly shows the weakness of the carbonyl group as well as C=N upon complexation.

2.2. Description of the Crystal Structure

Single X-ray crystallography measurements show that [C16H20Br2CuN2O2] (1) crystallizes in the monoclinic system, with space group P21/m and crystallographic data listed in Table 1. The asymmetric unit of 1 (Figure 1) contains one molecular unit.
The coordination sphere of copper(II) consists of two bromides with an average Cu1–Br bond length of 2.372 Å, a hydroxyl oxygen Cu1–O2 of 1.987 Å, and Cu1–N1 of 2.067(10) Å. The Cu(II) is a square planar with Br1–Cu1–Br2 close to 90° (97.03(7)°). The furan and tertiary carbon in the adamantyl (C7) group and the amide arm (N2 and C6) are aligned in a coplanar disposition. All bond lengths and angles are in agreement with those reported for similar copper(II) complexes [32,33,34]. The structure of crystal 1 is stabilized by the presence of hydrogen bonds between the bromine atoms and the L ligands (N2-H···O1, 2.665(2) Å). Figure 2 shows the packing of 1 and Figure 3 describes the 1D-layer formed from these weak interactions in 1.

2.3. DFT Calculations

The stability of the square planar geometry in 1 was studied by DFT (6-31G(d)/B3LYP) calculations. Overall, we have designed two different models; one is built by enforcing the coordination around the copper atom to be square planar (SP), and the other as a distorted tetrahedron (DT). In the case of SP, the calculations lead to many negative vibration modes. This means unstable optimization with no global minima. The optimization of the monomer with a copper as DT was ended with no imaginary or negative modes. This means that the coordination of the monomer molecule would not be SP. This concludes that the in silico (gaseous) structure is not in agreement with the solid-state structure of 1 (Table 2) which is SP. A literature survey of LCuBr2 complexes shows that many systems have been reported with distorted geometry and only a few possess square planar geometry [35,36,37]. Therefore, we optimized a dimer (Figure 4 and Figure 5) to try mimicking the crystallographic structure. The results obtained indicated that there are no negative or imaginary modes and the copper coordination was almost square planar. These findings may indicate that the stability of such a type of coordination system might be due to the interactions (even very weak) in the solid state in 1. Figure 3 shows CH···Br intermolecular interaction in 1 with C···Br (3.776 Å) and C···H···Br (157.73°). Furthermore, Mulliken and ESP charge calculations show strong interactions between Br1 (−0.4) from a monomer with the Cu1 (+0.5) (Table 2) from others along b-axis which stabilize the square planar coordination (Figure 4). This could be due to the highly distorted octahedron. To confirm the possibility of having a distorted octahedron, we examined the frontier molecular orbitals and found that no molecular interactions were observed (Figure 5). Such findings unequivocally confirm that, in such complex, copper adopts a square planar geometry, which is rarely described in literature.

3. Materials and Methods

FTIR spectra were recorded with a Nicolet Impact 400 Fourier transform infrared Spectrophotometer (Madison, WI) in the 400–4000 cm−1 region. KBr discs for solid samples were made by grinding 2 mg of the solid sample with about 0.2 g of KBr. A background spectrum was subtracted. Mass spectrometry experiments were performed in the negative mode on mass spectrometer (APEX-4 (7 Tesla), Bruker Daltonics, Bremen, Germany) equipped with an ESI source.

3.1. Synthesis of the Copper(II) Complex 1

The copper(II) complex of N′-(furan-2-ylmethylene)adamantne-1-carbohydrazide ligand (L) was prepared by the addition of a hot ethanol solution of the previously reported ligand (L) by our group [30,31] to an equimolar amount of copper(II) bromide [38]. The complex was precipitated immediately during stirring of the reaction mixture on a magnetic stirrer at room temperature. The precipitate was filtered, washed with cold ethanol, and dried at 60 °C in a vacuum oven for 2 hours to give the copper complex. Orange block-like crystals suitable for X-ray analysis were obtained: characteristics FTIR (KBr): ν = 1593 (s), 1526 (s), 525 (m). ESI-HRMS (m/z): 491.91148 calculated for C16H19Br2CuN2O2 [M − H]−.

3.2. X-ray Difraction Study

Single-crystal X-ray diffraction data were collected using an Oxford Diffraction XCalibur, equipped with (Mo) X-ray Source (λ  =  0.71073 Å) at 291(2) K. Data collection, reduction, and cell refinement were performed using the software package CrysAlisPro [39]. Analytical absorption corrections were applied using spherical harmonics implemented in SCALE3 (ABSPACK) scaling algorithm. Crystal structure was solved by direct methods, using the program OLEX2, followed by Fourier synthesis, and refined on F2 with SHELXL-97 [40]. Anisotropic least-squares refinement of non-H atoms was applied. All crystallographic plots were obtained using the CrystalMaker program [41]. A summary of the crystallographic data and structure refinement parameters is given in Table 1. Crystallographic data (excluding structure factors) for the structures in this paper have been deposited with the Cambridge Crystallographic Data Centre, CCDC, 12 Union Road, Cambridge CB21EZ, UK. Copies of the data can be obtained free of charge on quoting the depository number CCDC-1824898 (Fax: +44-1223-336-033; E-Mail: [email protected], http:// www.ccdc.cam.ac.uk). Selected bond lengths and angles are listed in Table 2.

3.3. Computational Details

B3LYP density functional theory (DFT) calculations were performed using the Gaussian 09 with its visual interference Gaussview 5 [42]. Due to the issues related to cost, 6-311G(d) basis sets were used for C, H, N, O, Br, and Cu. No symmetry constraint was imposed in the optimization. The vibration analyses were carried out to insure the non-existence of any negative/imaginary modes.

4. Conclusions

A new copper complex with N′-(furan-2-ylmethylene)adamantne-1-carbohydrazide is prepared and its crystal structure was determined. The coordination of the copper(II) is square planar which is rare. We carried out a DFT calculation and show that this coordination is not stable in (in silico) the gaseous phase. The stability of such coordination in the solid state may be attributed to the existence of weak intermolecular forces between Br and CH.

Acknowledgments

We wish to thank the Deanship of Academic Research (The University of Jordan) for financial support.

Author Contributions

M.A.K. and R.A.A. conceived and designed the experiments; A.M.J. performed the experiments; R.A.A. contributed reagents and materials, M.A.K. and M.A.A. analyzed the data and wrote the paper.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Rollas, S.; Gulerman, N.; Erdeniz, H. Synthesis and antimicrobial activity of some new hydrazones of 4-fluorobenzoic acid hydrazide and 3-acetyl-2, 5-disubstituted-1, 3, 4-oxadiazolines. Il Farmaco 2002, 57, 171–174. [Google Scholar] [CrossRef]
  2. Bedia, K.; Elçin, O.; Seda, U.; Fatma, K.; Nathaly, S.; Sevim, R.; Dimoglo, A. Synthesis and characterization of novel hydrazide–hydrazones and the study of their structure–antituberculosis activity. Eur. J. Med. Chem. 2006, 41, 1253–1261. [Google Scholar] [CrossRef] [PubMed]
  3. Narang, R.; Narasimhan, B.; Sharma, S. A review on biological activities and chemical synthesis of hydrazide derivatives. Curr. Med. Chem. 2012, 19, 569–612. [Google Scholar] [CrossRef] [PubMed]
  4. Vicini, P.; Zani, F.; Cozzini, P.; Doytchinova, I. Hydrazones of 1, 2-benzisothiazole hydrazides: synthesis, antimicrobial activity and QSAR investigations. Eur. J. Med. Chem. 2002, 37, 553–564. [Google Scholar] [CrossRef]
  5. Ersan, S.; Nacak, S.; Berkem, R.; Ozden, T. Synthesis and antimicrobial activities of 2-[(alpha-methylbenzylidene)-hydrazino] benzoxazoles. Arzneim.-Forsch. 1997, 47, 963–965. [Google Scholar]
  6. Yildir, I.; Perçiner, H.; Sahin, M.F.; Abbasoglu, U. Hydrazones of [(2-Benzothiazolylthio) acetyl] hydrazine: Synthesis and Antimicrobial Activity. Arch. Pharm. 1995, 328, 547–549. [Google Scholar] [CrossRef]
  7. Cesur, Z.; Büyüktimkin, S.; Büyüktimkin, N.; Derbentli, S. Synthesis and Antimicrobial Evaluation of Some Arylhydrazones of 4-[(2-Methylimidazo [1, 2-a] pyridine-3-yl) azo] benzoic Acid Hydrazide. Arch. Pharm. 1990, 323, 141–144. [Google Scholar] [CrossRef]
  8. Vittorio, F.; Ronsisvalle, G.; Marrazzo, A.; Blandini, G. Synthesis and antimicrobial evaluation of 4-phenyl-3-isoquinolinoyl-hydrazones. Il Farmaco 1995, 50, 265–272. [Google Scholar] [PubMed]
  9. Rasras, A.; Al-Tel, T.; Al-Aboudi, A.; Al-Qawasmeh, R. Synthesis and antimicrobial activity of cholic acid hydrazone analogues. Eur. J. Med. Chem. 2010, 45, 2307–2313. [Google Scholar] [CrossRef] [PubMed]
  10. Vicini, P.; Incerti, M.; Doytchinova, I.A.; La Colla, P.; Busonera, B.; Loddo, R. Synthesis and antiproliferative activity of benzo [d] isothiazole hydrazones. Eur. J. Med. Chem. 2006, 41, 624–632. [Google Scholar] [CrossRef] [PubMed]
  11. Rollas, S.; Küçükgüzel, S.G. Biological activities of hydrazone derivatives. Molecules 2007, 12, 1910. [Google Scholar] [CrossRef] [PubMed]
  12. Al-Hazmi, G.A.; El-Asmy, A.A. Synthesis, spectroscopy and thermal analysis of copper (II) hydrazone complexes. J. Coord. Chem. 2009, 62, 337–345. [Google Scholar] [CrossRef]
  13. Dawkins, A.T.; Gallager, L.R.; Togo, Y.; Hornick, R.B.; Harris, B.A. Studies on induced influenza in man: II. Double-blind study designed to assess the prophylactic efficacy of an analogue of amantadine hydrochloride. J. Am. Med. Assoc. 1968, 203, 1095–1099. [Google Scholar] [CrossRef]
  14. Çalıs, Ü.; Yarıma, M.; Köksal, M.; Özalp, M. Synthesis and antimicrobial activity evaluation of some new adamantane derivatives. Arzneim.-Forsch. 2002, 52, 778–781. [Google Scholar] [CrossRef]
  15. Liu, J.; Obando, D.; Liao, V.; Lifa, T.; Codd, R. The many faces of the adamantyl group in drug design. Eur. J. Med. Chem. 2011, 46, 1949–1963. [Google Scholar] [CrossRef] [PubMed]
  16. Kadi, A.A.; Al-Abdullah, E.S.; Shehata, I.A.; Habib, E.E.; Ibrahim, T.M.; El-Emam, A.A. Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1, 3, 4-thiadiazole derivatives. Eur. J. Med. Chem. 2010, 45, 5006–5011. [Google Scholar] [CrossRef] [PubMed]
  17. Antoniadou-Vyza, E.; Avramidis, N.; Kourounakis, A.; Hadjipetrou, L. Anti-inflammatory properties of new adamantane derivatives. Design, synthesis, and biological evaluation. Arch. Pharm. Pharm. Med. Chem. 1998, 331, 72–78. [Google Scholar] [CrossRef]
  18. Olson, S.; Aster, S.D.; Brown, K.; Carbin, L.; Graham, D.W.; Hermanowski-Vosatka, A.; LeGrand, C.B.; Mundt, S.S.; Robbins, M.A.; Schaeffer, J.M.; et al. Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1. Bioorg. Med. Chem. Lett. 2005, 15, 4359–4362. [Google Scholar] [CrossRef] [PubMed]
  19. Sondhi, S.; Dinodiaa, M.; Kumar, A. Synthesis, anti-inflammatory and analgesic activity evaluation of some amidine and hydrazone derivatives. Bioorg. Med. Chem. 2006, 14, 4657–4663. [Google Scholar] [CrossRef] [PubMed]
  20. Fernàndez, J.M.; Acevedo-Arauz, E.; Cetina-Rosado, R.; Macías-Ruvalcaba, N.; Toscano, R.A. Electrochemical studies of copper (II) complexes derived from bulky Schiff bases. The crystal structure of bis [N-(1-adamantyl)-salicylaldiminato] copper (II). Trans. Met. Chem. 1999, 24, 18–24. [Google Scholar] [CrossRef]
  21. Đorđević, M.; Jeremić, D.; Anđelković, K.; Pavlović, M.; Divjaković, V.; Ristović, M.; Brčeski, I. Cobalt (II) and cadmium (II) compounds with adamantane-1-sulfonic acid. J. Serb. Chem. Soc. 2012, 77, 1391–1399. [Google Scholar] [CrossRef]
  22. Franco, J.; Olmstead, M.; Hammons, J. Bis[1-(1-adamantyliminomethyl)-2-naphtholato-κ2N, O] cobalt (II). Acta Crystallogr. Sect. E 2008, 64, m1223. [Google Scholar] [CrossRef] [PubMed]
  23. Lee, Y.; Karlin, K.D. Model complexes for copper-containig enzymes. In Concepts and Models in Bioinorganic Chemistry; Kraatz, H.-B., Metzler-Nolte, N., Eds.; Wiley-VCH: Weinheim, Germany, 2006; pp. 363–396. ISBN 9783527313051. [Google Scholar]
  24. Lippard, S.J.; Berg, J.M. Principles of Bioinorganic Chemistry; University Science Books: Mill Valley, CA, USA, 1994; pp. 1–6. ISBN 0935702725. [Google Scholar]
  25. Da Silva, J.F.; Williams, R.J.P. The Biological Chemistry of the Elements: the Inorganic Chemistry of Life, 2nd ed.; Clarendon: Oxford, UK, 2001; pp. 7–26. ISBN 9780198508489. [Google Scholar]
  26. Teyssot, M.-L.; Jarrousse, A.-S.; Chevry, A.; De Haze, A.; Beaudoin, C.; Manin, M.; Nolan, S.P.; Diez-Gonzalez, S.; Morel, L.; Gautier, A. Toxicity of Copper (I)–NHC Complexes Against Human Tumor Cells: Induction of Cell Cycle Arrest, Apoptosis, and DNA Cleavage. Chem. Eur. J. 2009, 15, 314–318. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. McGivern, T.J.P.; Afsharpour, S.; Marmion, C.J. Copper complexes as artificial DNA metallonucleases: From Sigman’s reagent to next generation anti-cancer agent? Inorg. Chim. Acta 2017, 472, 12–39. [Google Scholar] [CrossRef]
  28. Santini, C.; Pellei, M.; Gandin, V.; Porchia, M.; Tisato, F.; Marzano, C. Advances in Copper Complexes as Anticancer Agents. Chem. Rev. 2014, 114, 815–862. [Google Scholar] [CrossRef] [PubMed]
  29. Akitsu, T. A Metal Complex Incorporating Some Drug Molecules as Ligands. EC Pharmacol. Toxicol. 2017, ECO.01, 16–18. [Google Scholar]
  30. Al-Qawasmeh, R.A.; Salameh, B.; Alrazim, R.; Aldamen, M.; Voelter, W. Microwave Assisted Synthesis of New Adamantyltriazine Derivatives. Lett. Org. Chem. 2014, 11, 513–518. [Google Scholar] [CrossRef]
  31. Al-Aboudi, A.; Al-Qawasmeh, R.A.; Shahwan, A.; Mahmood, U.; Khalid, A.; Ul-Haq, Z. In-silico identification of the binding mode of synthesized adamantyl derivatives inside cholinesterase enzymes. Acta Pharmacol. Sin. 2015, 36, 879–886. [Google Scholar] [CrossRef] [PubMed]
  32. Zhou, X.-Q.; Li, Y.; Zhang, D.-Y.; Nie, Y.; Li, Z.-J.; Gu, W.; Liu, X.; Tian, J.-L.; Yan, S.-P. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis. Eur. J. Med. Chem. 2016, 114, 244–256. [Google Scholar] [CrossRef] [PubMed]
  33. Koval’chukovaa, O.V.; Zavodnikb, V.E.; Shestakovc, A.F.; Strashnovaa, S.B.; Zaitseva, B.E. Experimental and Theoretical Investigation of the Structure and Spectral Characteristics of Bis(4–aza–9–fluorenone)dibromocopper(II). Russ. J. Inorg. Chem. 2010, 55, 195–200. [Google Scholar] [CrossRef]
  34. Vela, S.; Deumal, M.; Turnbull, M.M.; Novoa, J.J. A theoretical analysis of the magnetic properties of the low-dimensional copper(II)X2(2-X-3-methylpyridine)2(X = Cl and Br) complexes. Theor. Chem. Acc. 2013, 132, 1331. [Google Scholar] [CrossRef]
  35. Posada, N.B.; Guimarães, M.A.; Padilha, D.S.; Resende, J.A.; Faria, R.B.; Lanznaster, M.; Amado, R.S.; Scarpellini, M. Influence of the secondary coordination sphere on the physical properties of mononuclear copper (II) complexes and their catalytic activity on the oxidation of 3, 5-di-tert-butylcatechol. Polyhedron 2018, 141, 30–36. [Google Scholar] [CrossRef]
  36. Piri, Z.; Moradi-Shoeili, Z.; Assoud, A. New copper (II) complex with bioactive 2–acetylpyridine-4N-p-chlorophenylthiosemicarbazone ligand: Synthesis, X-ray structure, and evaluation of antioxidant and antibacterial activity. Inorg. Chem. Commun. 2017, 84, 122–126. [Google Scholar] [CrossRef]
  37. Thomas, F.; Kochem, A.; Molloy, J.K.; Gellon, G.; Leconte, N.; Philouze, C.; Jarjayes, O.; Berthiol, F. A structurally characterized Cu (III) complex supported by a bis (anilido) ligand and its oxidative catalytic activity. Chem. Eur. J. 2017, 23, 13929–13940. [Google Scholar] [CrossRef]
  38. Singh, K.; Kumar, Y.; Parvesh, P.; Sharma, C.; Aneja, K. Metal-Based Biologically Active Compounds: Synthesis, Spectral, and Antimicrobial Studies of Cobalt, Nickel, Copper, and Zinc Complexes of Triazole-Derived Schiff Bases. Bioinorg. Chem. Appl. 2011, 2011, 901716–901726. [Google Scholar] [CrossRef] [PubMed]
  39. CrysAlis Software System; Version 1.171; Oxford Diffraction Ltd.: Oxford, England, 2002.
  40. SHELXL; Version 97; Program for X-ray Crystal Structure Refinement; University of Göttingen: Göttingen, Germany, 1997.
  41. Images generated using CrystalMaker(R), version 9; A crystal and molecular structures program for Mac and Windows (www.crystalmaker.com); CrystalMaker Software Ltd.: Oxford, UK, 2015.
  42. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Zakrzewski, V.G.; Montgomery, J.A., Jr.; Stratmann, R.E.; Burant, J.C.; et al. Gaussian 03; Revision 05; Gaussian Inc.: Pittsburgh, PA, USA, 2003. [Google Scholar]
Sample Availability: Samples of the compound 1 is available from the authors.
Molecules 23 00701 sch001 550
Scheme 1. Synthesis of copper(II) complex 1.
Scheme 1. Synthesis of copper(II) complex 1.
Molecules 23 00701 sch001
Molecules 23 00701 g001 550
Figure 1. Thermal ellipsoid drawing (50% probability level) of the asymmetric unit of 1.
Figure 1. Thermal ellipsoid drawing (50% probability level) of the asymmetric unit of 1.
Molecules 23 00701 g001
Molecules 23 00701 g002 550
Figure 2. Crystal packing along the c-axis of 1 shows the distorted octahedron around copper, the thermal ellipsoid drawing of 50%.
Figure 2. Crystal packing along the c-axis of 1 shows the distorted octahedron around copper, the thermal ellipsoid drawing of 50%.
Molecules 23 00701 g002
Molecules 23 00701 g003 550
Figure 3. Crystal packing of 1 in the ac-plane, dashed lines is the shortest weak interactions in 1.
Figure 3. Crystal packing of 1 in the ac-plane, dashed lines is the shortest weak interactions in 1.
Molecules 23 00701 g003
Molecules 23 00701 g004 550
Figure 4. (a) ESP (electrostatic potential); and (b) Mulliken charge calculations at level 6-31G(d)/B3LYP for the dimer of 1.
Figure 4. (a) ESP (electrostatic potential); and (b) Mulliken charge calculations at level 6-31G(d)/B3LYP for the dimer of 1.
Molecules 23 00701 g004
Molecules 23 00701 g005a 550Molecules 23 00701 g005b 550
Figure 5. Presentation of the HOMO–LUMO in 1 obtained at 6-31G(d)/B3LYP of theory. (a) HOMO-1; (b) HOMO; (c) LUMO; (d) LUMO+1.
Figure 5. Presentation of the HOMO–LUMO in 1 obtained at 6-31G(d)/B3LYP of theory. (a) HOMO-1; (b) HOMO; (c) LUMO; (d) LUMO+1.
Molecules 23 00701 g005aMolecules 23 00701 g005b
Table
Table 1. Crystal data and structure refinement parameters for 1.
Table 1. Crystal data and structure refinement parameters for 1.
Crystal SystemMonoclinic
T/K293(2)
Space groupP21/m
a/Å10.8030(8)
b/Å6.6115(8)
c/Å12.1264(12)
β/°101.124(8)
Volume/Å3849.9(3)
Z2
ρcalc g/cm31.937
μ/mm−15.997
F(000)490
RadiationMoKα (λ = 0.71073)
2Θ range for data collection/°6.848–51.348
Index ranges−13 ≤ h ≤ 13, −5 ≤ k ≤ 8, −13 ≤ l ≤ 14
Reflections collected3640
Independent reflections1754 [Rint = 0.0842, Rsigma = 0.1264]
Data/restraints/parameters1754/0/130
Goodness-of-fit on F21.017
Final R indexes [I ≥ 2σ (I)]R1 = 0.0751, wR2 = 0.1581
Final R indexes [all data]R1 = 0.1214, wR2 = 0.1902
Largest diff. peak/hole / e Å−31.12/−1.07
Table
Table 2. Selected bond distances (Å) and bond angles (°) for 1. Experimental, optimized dimer and monomer structural data are presented.
Table 2. Selected bond distances (Å) and bond angles (°) for 1. Experimental, optimized dimer and monomer structural data are presented.
Exp.Theo. Exp.Theo.
dimermonomer dimermonomer
Cu1-Br12.376(2)2.3792.287C7-C61.505(15)1.5211.935
Cu1-Br22.368(2)2.3232.298C7C81.519(10)1.5561.556
Cu1-O21.987(8)2.0942.036C7-C91.574(13)1.5481.556
Cu1-N12.067(10)2.0942.061C4-C51.307(17)1.3641.364
O2-C61.268(13)1.2411.243C4-C31.460(17)1.4241.423
O1-C21.385(14)1.3821.382C2-C31.351(17)1.3731.375
O1-C51.364(14)1.3621.361C8-C121.521(11)1.5451.545
N2-N11.381(13)1.3761.372C10-C91.515(16)1.5411.541
N2-C61.320(15)1.3571.364C10-C111.518(11)1.5411.543
N1-C11.250(14)1.2951.294C13-C121.526(10)1.5421.543
C1-C21.457(16)1.4331.432C12-C111.510(9)1.5421.542
Cu1···Cu13.9853.258-N2···O12.6652.7552.768
Cu1···Br13.3852.623-N1-Cu1-Br193.7(3)93.3996.55
Br2-Cu1-Br197.03(7)93.50109.09N1-Cu1-Br2169.3(3)156.42138.04
O2-Cu1-Br1173.9(2)163.45147.02Br1···N1N2C6O20.000−0.012−0.538
O2-Cu1-Br289.0(2)90.4595.43Br2···N1N2C6O20.000−0.0282.109
O2-Cu1-N180.3(4)77.0477.93Cu1···N1N2C6O20.0000.2770.355

Share and Cite

MDPI and ACS Style

Khanfar, M.A.; Jaber, A.M.; AlDamen, M.A.; Al-Qawasmeh, R.A. Synthesis, Characterization, Crystal Structure, and DFT Study of a New Square Planar Cu(II) Complex Containing Bulky Adamantane Ligand. Molecules 2018, 23, 701. https://doi.org/10.3390/molecules23030701

AMA Style

Khanfar MA, Jaber AM, AlDamen MA, Al-Qawasmeh RA. Synthesis, Characterization, Crystal Structure, and DFT Study of a New Square Planar Cu(II) Complex Containing Bulky Adamantane Ligand. Molecules. 2018; 23(3):701. https://doi.org/10.3390/molecules23030701

Chicago/Turabian Style

Khanfar, Monther A., Areej M. Jaber, Murad A. AlDamen, and Raed A. Al-Qawasmeh. 2018. "Synthesis, Characterization, Crystal Structure, and DFT Study of a New Square Planar Cu(II) Complex Containing Bulky Adamantane Ligand" Molecules 23, no. 3: 701. https://doi.org/10.3390/molecules23030701

APA Style

Khanfar, M. A., Jaber, A. M., AlDamen, M. A., & Al-Qawasmeh, R. A. (2018). Synthesis, Characterization, Crystal Structure, and DFT Study of a New Square Planar Cu(II) Complex Containing Bulky Adamantane Ligand. Molecules, 23(3), 701. https://doi.org/10.3390/molecules23030701

Article Metrics

Back to TopTop